Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-21-059311
Filing Date
2021-05-03
Accepted
2021-04-30 18:44:56
Documents
1
Group Members
CASEY M. TANSEYJONATHAN D. ROOTPRESIDIO MANAGEMENT GROUP XI, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tm2114826d1_sc13d.htm SC 13D 111792
  Complete submission text file 0001104659-21-059311.txt   113441
Mailing Address 2735 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2735 SAND HILL ROAD MENLO PARK CA 94025 (650) 854-9080
U.S. Venture Partners XI, L.P. (Filed by) CIK: 0001619539 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE, 54TH FLR. NEW YORK NY 10022
Business Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE, 54TH FLR. NEW YORK NY 10022 212-739-6451
Edgewise Therapeutics, Inc. (Subject) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92424 | Film No.: 21880575
SIC: 2834 Pharmaceutical Preparations